Back to News
Market Impact: 0.42

The SpaceX IPO Could Spark a "Risk-On" Rally: Here Are 2 Stocks That Could Benefit

IPOs & SPACsTechnology & InnovationCompany FundamentalsAnalyst InsightsMarket Technicals & FlowsInvestor Sentiment & Positioning

SpaceX is preparing for a June 12 IPO with a first-sale valuation of about $1.77 trillion after cutting its target by roughly $200 billion, creating a key test for risk appetite. The article argues a strong debut could lift sentiment across growth and space-tech stocks, potentially helping Micron, up 898% over 12 months, and Rocket Lab, up about 74% year to date but roughly 20% off its high. The main focus is valuation ripple effects rather than new operating data.

Analysis

The key market effect here is not SpaceX itself, but the change in liquidity psychology around high-duration growth. A clean IPO reception would likely compress the equity risk premium for adjacent “story stocks,” which matters most for names like MU that already trade as quasi-macro factors in the AI complex. In other words, the IPO is a sentiment event first and a space-sector event second: if it clears at a premium and holds, it can extend the bid for cyclical semis and other high-beta leaders for several sessions to a few weeks.

The second-order loser is any stock whose valuation depends on scarcity of public comps in private-space/launch infrastructure. A strong SpaceX debut would create a new reference point that could cap multiples for weaker adjacent names, but in the near term it may actually help them by legitimizing the category. For RKLB specifically, the risk/reward is asymmetric because the stock is being repriced off narrative rather than near-term cash flow, so it can overshoot in either direction on sentiment alone; that makes it a cleaner trading vehicle than a fundamental one around the IPO window.

The contrarian read is that the market may be underestimating how much of the upside is already embedded in the first-day print. When the implied private valuation is that elevated, a “successful” IPO can still disappoint if post-deal supply overwhelms incremental demand or if lockup-adjacent positioning turns into a quick flip. That creates a tactical setup where the first reaction can be bullish for beta, but the second-order effect over 1-4 weeks may be mean reversion if the IPO becomes a funding source rather than a durable risk-on signal.